Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.

Bear HD, Wan W, Robidoux A, Rubin P, Limentani S, White RL Jr, Granfortuna J, Hopkins JO, Oldham D, Rodriguez A, Sing AP.

J Surg Oncol. 2018 Sep;118(4):722. doi: 10.1002/jso.24798. Epub 2017 Jul 28. No abstract available.

PMID:
30295942
2.

Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement.

Klotz L, Shayegan B, Guillemette C, Collins LL, Gotto G, Guérette D, Jammal MP, Pickles T, Richard PO, Saad F.

Can Urol Assoc J. 2018 Feb;12(2):30-37. doi: 10.5489/cuaj.5116. Epub 2017 Dec 19.

3.

Recommandations de l'Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.

Rendon RA, Mason RJ, Marzouk K, Finelli A, Saad F, So A, Violette P, Breau RH.

Can Urol Assoc J. 2017 Oct;11(10):298-309. doi: 10.5489/cuaj.4888. No abstract available.

4.

Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials.

Heller G, McCormack R, Kheoh T, Molina A, Smith MR, Dreicer R, Saad F, de Wit R, Aftab DT, Hirmand M, Limon A, Fizazi K, Fleisher M, de Bono JS, Scher HI.

J Clin Oncol. 2018 Feb 20;36(6):572-580. doi: 10.1200/JCO.2017.75.2998. Epub 2017 Dec 22.

5.

Hematoxylin and Eosin Counterstaining Protocol for Immunohistochemistry Interpretation and Diagnosis.

Grosset AA, Loayza-Vega K, Adam-Granger É, Birlea M, Gilks B, Nguyen B, Soucy G, Tran-Thanh D, Albadine R, Trudel D.

Appl Immunohistochem Mol Morphol. 2017 Dec 21. doi: 10.1097/PAI.0000000000000626. [Epub ahead of print]

PMID:
29271792
6.

A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.

Bandini M, Marchioni M, Preisser F, Nazzani S, Tian Z, Fossati N, Gandaglia G, Shariat SF, Montorsi F, Saad F, Briganti A, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2017 Dec 14. pii: S2405-4569(17)30269-9. doi: 10.1016/j.euf.2017.11.013. [Epub ahead of print]

PMID:
29249688
7.

Phase 1 Trial Evaluating Safety of Pulmonary Artery Sealing With Ultrasonic Energy in VATS Lobectomy.

Goudie E, Oliveira RL, Thiffault V, Jouquan A, Lafontaine E, Ferraro P, Liberman M.

Ann Thorac Surg. 2018 Jan;105(1):214-220. doi: 10.1016/j.athoracsur.2017.08.013. Epub 2017 Nov 20.

PMID:
29157742
8.

Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma.

Jamal R, Lapointe R, Cocolakis E, Thébault P, Kazemi S, Friedmann JE, Dionne J, Cailhier JF, Bélanger K, Ayoub JP, Le H, Lambert C, El-Hajjar J, van Kempen LC, Spatz A, Miller WH Jr.

J Immunother Cancer. 2017 Nov 21;5(1):83. doi: 10.1186/s40425-017-0290-x.

9.

Deep Learning: A Primer for Radiologists.

Chartrand G, Cheng PM, Vorontsov E, Drozdzal M, Turcotte S, Pal CJ, Kadoury S, Tang A.

Radiographics. 2017 Nov-Dec;37(7):2113-2131. doi: 10.1148/rg.2017170077. Review.

PMID:
29131760
10.

Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study.

Bandini M, Pompe RS, Marchioni M, Zaffuto E, Gandaglia G, Fossati N, Cindolo L, Montorsi F, Briganti A, Saad F, Karakiewicz PI.

Int Urol Nephrol. 2018 Jan;50(1):71-78. doi: 10.1007/s11255-017-1744-2. Epub 2017 Nov 11.

PMID:
29129028
11.

First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy.

Bandini M, Marchioni M, Pompe RS, Tian Z, Gandaglia G, Fossati N, Abdollah F, Graefen M, Montorsi F, Saad F, Shariat SF, Briganti A, Karakiewicz PI.

BJU Int. 2018 Apr;121(4):592-599. doi: 10.1111/bju.14074. Epub 2017 Nov 29.

PMID:
29124911
12.

Development and characterization of a handheld hyperspectral Raman imaging probe system for molecular characterization of tissue on mesoscopic scales.

St-Arnaud K, Aubertin K, Strupler M, Madore WJ, Grosset AA, Petrecca K, Trudel D, Leblond F.

Med Phys. 2018 Jan;45(1):328-339. doi: 10.1002/mp.12657. Epub 2017 Nov 27.

PMID:
29106741
13.

Canadian Men's perspectives about active surveillance in prostate cancer: need for guidance and resources.

Fitch M, Pang K, Ouellet V, Loiselle C, Alibhai S, Chevalier S, Drachenberg DE, Finelli A, Lattouf JB, Sutcliffe S, So A, Tanguay S, Saad F, Mes-Masson AM.

BMC Urol. 2017 Oct 27;17(1):98. doi: 10.1186/s12894-017-0290-7.

14.

Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis.

Bandini M, Pompe RS, Marchioni M, Tian Z, Gandaglia G, Fossati N, Tilki D, Graefen M, Montorsi F, Shariat SF, Briganti A, Saad F, Karakiewicz PI.

World J Urol. 2018 Jan;36(1):7-13. doi: 10.1007/s00345-017-2102-9. Epub 2017 Oct 23.

PMID:
29063268
15.

Dimension reduction technique using a multilayered descriptor for high-precision classification of ovarian cancer tissue using optical coherence tomography: a feasibility study.

St-Pierre C, Madore WJ, De Montigny E, Trudel D, Boudoux C, Godbout N, Mes-Masson AM, Rahimi K, Leblond F.

J Med Imaging (Bellingham). 2017 Oct;4(4):041306. doi: 10.1117/1.JMI.4.4.041306. Epub 2017 Oct 12.

16.

Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohort.

Zanaty M, Alnazari M, Ajib K, Lawson K, Azizi M, Rajih E, Alenizi A, Hueber PA, Tolmier C, Meskawi M, Saad F, Pompe RS, Karakiewicz PI, El-Hakim A, Zorn KC.

World J Urol. 2018 Jan;36(1):1-6. doi: 10.1007/s00345-017-2105-6. Epub 2017 Oct 20.

PMID:
29052761
17.

Sulfites inhibit the growth of four species of beneficial gut bacteria at concentrations regarded as safe for food.

Irwin SV, Fisher P, Graham E, Malek A, Robidoux A.

PLoS One. 2017 Oct 18;12(10):e0186629. doi: 10.1371/journal.pone.0186629. eCollection 2017.

18.

Engineered in-vitro cell line mixtures and robust evaluation of computational methods for clonal decomposition and longitudinal dynamics in cancer.

Farahani H, de Souza CPE, Billings R, Yap D, Shumansky K, Wan A, Lai D, Mes-Masson AM, Aparicio S, P Shah S.

Sci Rep. 2017 Oct 18;7(1):13467. doi: 10.1038/s41598-017-13338-8.

19.

If your hospital has RATS, do not exterminate.

Liberman M.

J Thorac Cardiovasc Surg. 2018 Feb;155(2):777. doi: 10.1016/j.jtcvs.2017.09.081. Epub 2017 Sep 23. No abstract available.

PMID:
29042099
20.

Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers.

Labrie M, De Araujo LOF, Communal L, Mes-Masson AM, St-Pierre Y.

Sci Rep. 2017 Oct 16;7(1):13244. doi: 10.1038/s41598-017-13802-5.

Supplemental Content

Loading ...
Support Center